Annual FDA/PhUSE Computational Science Symposium

, to be held on March 18th and 19th 2013 in
  Silver Spring, Maryland, provides the premier forum for industry and FDA to collaborate in the realm of
  computational science.
  
  PhUSE, an independent, non‐profit community of professionals focused around the advancement of clinical
  information is proud to co‐sponsor, along with The Food and Drug Administration, the Annual FDA/PhUSE
  Computational Science Symposium, to be held on March 18th and 19th 2013 in Silver Spring, Maryland, USA.
  
  The symposium is an opportunity for FDA, the pharmaceutical industry, academia, and other computational
  science stakeholders to meet in a collaborative environment.
  
  “The symposium provides a platform for FDA and industry to collaborate with the goal of closing some of the
  gaps we face in delivering information to the FDA and solving the challenges FDA deals with during their
  review cycle,” says Chris Decker, PhUSE FDA Liaison and Vice President, Life Sciences Practice at d‐Wise.
  
  A vital part of the stakeholder collaboration resulted from the creation of working groups at the annual
  symposium in 2012. The working group areas of focus are: Data Quality, Data Standards, Standard Scripts,
  Non‐clinical. The 2013 Symposium will provide a venue for these groups to continue their collaborative efforts,
  as well as to share the exciting progress that they have made in 2012. Additional projects are being formed to
  address increasing challenges to the access and review of data identified since the previous meeting.
  
  Participants are encouraged to submit abstracts for a poster session at the Symposium. Abstracts are due by
  January 31st 2013.
  
  The Symposium will be held at the Silver Spring Civic Building at Veterans Plaza.